Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic therapy for asthma.

S W Stoloff1

  • 1University of Nevada School of Medicine, Reno, USA.

Clinical Cornerstone
|February 22, 2000
PubMed
Summary
This summary is machine-generated.

Pharmacologic therapy for asthma involves daily long-term control medications and quick-relief medications to manage this chronic respiratory condition. Effective asthma management requires a stepwise approach and strong clinician-patient partnerships for optimal symptom control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

The Journal of allergy and clinical immunology·2012
Same author

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.

Allergy·2010
Same author

The role of LTRAs in the management of persistent asthma.

Postgraduate medicine·2009
Same author

Introduction. The growing importance of LTRAs in asthma control.

Postgraduate medicine·2009
Same author

A new perspective on concepts of asthma severity and control.

The European respiratory journal·2008
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

Allergy·2008
Same journal

Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options.

Clinical cornerstone·2009
Same journal

Guiding clinical decisions on abdominal obesity and cardiometabolic risk.

Clinical cornerstone·2009
Same journal

Overweight and obesity: the pathogenesis of cardiometabolic risk.

Clinical cornerstone·2009
Same journal

Obesity as a disease state: a new paradigm for diagnosis and treatment.

Clinical cornerstone·2009
Same journal

Pathogenesis of cardiometabolic risk as it relates to overweight and obesity. Introduction.

Clinical cornerstone·2009
Same journal

Should clinicians routinely determine rhinitis subtype on initial diagnosis and evaluation? A debate among experts.

Clinical cornerstone·2009
See all related articles

Area of Science:

  • Pulmonology
  • Pharmacology
  • Clinical Medicine

Background:

  • Asthma is a chronic respiratory disorder characterized by recurrent episodes of airflow limitation, mucus production, and cough.
  • Effective management of asthma necessitates pharmacologic interventions to prevent and control symptoms, reduce exacerbations, and reverse airflow obstruction.
  • Current treatment guidelines are based on the National Asthma Education and Prevention Program Expert Panel Report II (1997).

Purpose of the Study:

  • To outline the principles of pharmacologic therapy for asthma management.
  • To categorize asthma medications into long-term-control and quick-relief classes.
  • To emphasize key considerations in selecting appropriate pharmacologic strategies for persistent asthma.

Main Methods:

Related Experiment Videos

  • Classification of asthma medications into two primary categories: long-term-control and quick-relief.
  • Description of the role and administration of each medication class.
  • Discussion of a stepwise approach for long-term asthma management.
  • Highlighting the importance of clinician-patient partnership and patient education.

    • Main Results:

    • Pharmacologic therapy is essential for preventing and controlling asthma symptoms and exacerbations.
    • Long-term-control medications are for daily use to maintain asthma control.
    • Quick-relief medications are for prompt reversal of acute airflow obstruction.

    Conclusions:

    • Persistent asthma requires a combination of long-term-control and quick-relief medications.
    • Selection of pharmacologic therapy involves considering medication type, route of administration, and a stepwise management plan.
    • A collaborative clinician-patient strategy with continuous patient education is crucial for achieving and maintaining asthma control.